Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Variations in radioiodine ablation: decision-making after total thyroidectomy.
Maas O, Forrer F, Maas M, Panje CM, Blautzik J, Brühlmeier M, Engel-Bicik I, Giovanella L, Haldemann A, Kamel ME, Kneifel S, Rottenburger C, Schaefer N, Walter MA, Weidner S, Putora PM. Maas O, et al. Among authors: forrer f. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):554-560. doi: 10.1007/s00259-019-04557-4. Epub 2019 Nov 9. Eur J Nucl Med Mol Imaging. 2020. PMID: 31707428 Free article.
Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides.
Mansi R, Wang X, Forrer F, Kneifel S, Tamma ML, Waser B, Cescato R, Reubi JC, Maecke HR. Mansi R, et al. Among authors: forrer f. Clin Cancer Res. 2009 Aug 15;15(16):5240-9. doi: 10.1158/1078-0432.CCR-08-3145. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671861
Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with 90Y-DOTATOC Using Diffusion Weighted and Dynamic Contrast-Enhanced MRI.
Weikert T, Maas OC, Haas T, Klarhöfer M, Bremerich J, Forrer F, Sauter AW, Sommer G. Weikert T, et al. Among authors: forrer f. Contrast Media Mol Imaging. 2019 Nov 11;2019:1517208. doi: 10.1155/2019/1517208. eCollection 2019. Contrast Media Mol Imaging. 2019. PMID: 31787860 Free PMC article.
Early response monitoring during [177Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study.
Neubauer MC, Nicolas GP, Bauman A, Fani M, Nitzsche E, Afshar-Oromieh A, Forrer F, Rentsch C, Stenner F, Templeton A, Schäfer N, Wild D, Chirindel A; all investigators on behalf of the SSNM Therapy Working Group. Neubauer MC, et al. Among authors: forrer f. Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1185-1193. doi: 10.1007/s00259-023-06536-2. Epub 2023 Dec 1. Eur J Nucl Med Mol Imaging. 2024. PMID: 38038755 Free PMC article.
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial.
Cordier D, Forrer F, Bruchertseifer F, Morgenstern A, Apostolidis C, Good S, Müller-Brand J, Mäcke H, Reubi JC, Merlo A. Cordier D, et al. Among authors: forrer f. Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1335-44. doi: 10.1007/s00259-010-1385-5. Epub 2010 Feb 16. Eur J Nucl Med Mol Imaging. 2010. PMID: 20157707 Free article. Clinical Trial.
64 results